Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)
China · Delayed Price · Currency is CNY 8.68
-0.02 (-0.23%)
Aug 24, 2026, 3:00 PM CST
Jiangsu Nanfang Medical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 42.98 | 25.86 | 50 | 95.67 | 127.82 | 152.82 |
Trading Asset Securities | 22.5 | 22.5 | 22.52 | 22.52 | 21.23 | 20 |
Cash & Short-Term Investments | 65.48 | 48.35 | 72.53 | 118.2 | 149.04 | 172.82 |
Cash Growth | 18.68% | -33.33% | -38.64% | -20.70% | -13.76% | -46.86% |
Accounts Receivable | 119.86 | 114.99 | 104.9 | 156.53 | 170.34 | 139.51 |
Other Receivables | 11.08 | 14.9 | 25.5 | 9.65 | 50.07 | 13.6 |
Receivables | 130.94 | 129.9 | 130.39 | 166.18 | 220.41 | 153.11 |
Inventory | 114.19 | 138.82 | 188.9 | 267.58 | 289.1 | 216.81 |
Other Current Assets | 6.1 | 4.93 | 8.46 | 17.58 | 19.79 | 45.15 |
Total Current Assets | 316.71 | 322 | 400.28 | 569.54 | 678.35 | 587.89 |
Property, Plant & Equipment | 444.58 | 455.74 | 496.51 | 557.57 | 632.16 | 518.73 |
Long-Term Investments | 65.41 | 63.22 | 63.11 | 61.72 | 60.57 | 59.75 |
Other Intangible Assets | 40.39 | 40.78 | 42.33 | 39.64 | 40.37 | 36.18 |
Long-Term Deferred Tax Assets | 39.87 | 39.43 | 48.37 | 38.63 | 36.82 | 22.2 |
Long-Term Deferred Charges | 5.33 | 5.83 | 4.87 | 5.43 | 6.95 | 9.07 |
Other Long-Term Assets | 0.37 | 0.95 | 1.08 | 4.8 | 2.23 | 1.37 |
Total Assets | 912.66 | 927.94 | 1,057 | 1,277 | 1,457 | 1,235 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 245.76 | 245.8 | 223.1 | 215.41 | 278.03 | 170.86 |
Accrued Expenses | 8.86 | 16.68 | 15.93 | 10.71 | 16.83 | 15.24 |
Short-Term Debt | 339.82 | 344.95 | 451.93 | 452.03 | 430.87 | 352.23 |
Current Portion of Long-Term Debt | 37.03 | 35.06 | 23.45 | 16.47 | 24.84 | - |
Current Portion of Leases | - | - | 0.42 | 0.4 | 0.56 | 0.11 |
Current Income Taxes Payable | 8.64 | 0.14 | 0.03 | 0.05 | 0.14 | 2.28 |
Current Unearned Revenue | 12.59 | 8.7 | 5.31 | 6.13 | 5.24 | 4.72 |
Other Current Liabilities | 7.43 | 12.05 | 20.09 | 90.72 | 51.19 | 39.62 |
Total Current Liabilities | 660.14 | 663.38 | 740.26 | 791.92 | 807.7 | 585.06 |
Long-Term Debt | 67 | 73.83 | 21.13 | - | 16.59 | - |
Long-Term Leases | - | - | - | 0.42 | 0.64 | 1.45 |
Long-Term Unearned Revenue | 7.78 | 7.94 | 8.58 | 7.58 | 8.06 | 8.55 |
Long-Term Deferred Tax Liabilities | 0.97 | 1.05 | 2.16 | 3.19 | 2.98 | 2.93 |
Other Long-Term Liabilities | 0.57 | 0.57 | - | - | - | 0.9 |
Total Liabilities | 736.45 | 746.77 | 772.14 | 803.11 | 835.96 | 598.9 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 289.04 | 289.04 | 289.04 | 292.47 | 292.47 | 292.47 |
Additional Paid-In Capital | 106.24 | 106.24 | 106.24 | 120.75 | 120.75 | 120.75 |
Retained Earnings | -223.19 | -218.1 | -116.38 | 74.28 | 221.7 | 236.35 |
Treasury Stock | - | - | - | -18.6 | -18.6 | -18.6 |
Comprehensive Income & Other | - | - | 0.39 | 0.36 | 0.34 | 0.21 |
Total Common Equity | 172.1 | 177.19 | 279.29 | 469.27 | 616.66 | 631.18 |
Minority Interest | 4.1 | 3.98 | 5.12 | 4.95 | 4.82 | 5.11 |
Shareholders' Equity | 176.2 | 181.17 | 284.41 | 474.22 | 621.48 | 636.3 |
Total Liabilities & Equity | 912.66 | 927.94 | 1,057 | 1,277 | 1,457 | 1,235 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 443.85 | 453.84 | 496.93 | 469.32 | 473.5 | 353.8 |
Net Cash (Debt) | -378.37 | -405.48 | -424.41 | -351.13 | -324.46 | -180.98 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -1.31 | -1.40 | -1.47 | -1.21 | -1.11 | -0.64 |
Filing Date Shares Outstanding | 289.04 | 289.04 | 289.04 | 292.47 | 292.47 | 292.47 |
Total Common Shares Outstanding | 289.04 | 289.04 | 289.04 | 292.47 | 292.47 | 292.47 |
Working Capital | -343.42 | -341.38 | -339.98 | -222.39 | -129.35 | 2.83 |
Book Value Per Share | 0.60 | 0.61 | 0.97 | 1.60 | 2.11 | 2.16 |
Tangible Book Value | 131.71 | 136.41 | 236.95 | 429.63 | 576.29 | 595.01 |
Tangible Book Value Per Share | 0.46 | 0.47 | 0.82 | 1.47 | 1.97 | 2.03 |
Buildings | - | 467.75 | 457.79 | 437.75 | 420.73 | 296.04 |
Machinery | - | 286.37 | 288.77 | 326.25 | 325 | 235.84 |
Construction In Progress | - | - | 7.22 | 8.67 | 54.04 | 114.65 |